Most important take away

The venture industry is at a generational turning point: legacy multi-stage funds have industrialized into asset managers where portfolio services exist to scale the VCs, not the founders, and where consensus decision-making strips out the outlier conviction that produces fund-returners. The opportunity (for founders and new GPs alike) is to favor focused, boutique partnerships with single-trigger decision-making, light reserves, and direct GP-founder relationships over brand and bureaucracy.

Summary

Actionable insights and patterns from the conversation:

Career and operating advice for founders

• Pick investors for the relationship at the early stage and for price/staying-out-of-the-way at the growth stage. The “do no harm” investor already beats 80% of the industry; at seed/A, add a partner who will pick up the phone at 11pm on a Saturday.
• Don’t be seduced by the brand. Big brand VCs help mostly with follow-on funding, not with hiring (it tends to attract the wrong people who chase logos), and not meaningfully with customers. Optimize for an experienced partner with time for you.
• Treat valuation like a forward commitment, not a scoreboard. Stebbings’ frame: “you pick the price, but you must be 90% confident you can 3x it by the next round.” Founders pitched this way actually choose smaller, more defensible numbers (e.g., $15M instead of $25M at seed).
• Don’t over-stretch on price. Companies that raised at unrealistic 2021 marks are losing morale and cultural momentum because employees know the valuation isn’t real. Graduated, deliberate fundraising is winning.
• Pre-PMF, execution failures are mostly about founder grit and learning velocity, not missing OKRs. OKRs are largely bullshit at the early stage.
• Post-PMF, the #1 cause of broken execution is hiring, especially go-to-market leadership. Founders should regularly assess “do I have the right people in these seats?” against what great looks like 1-3 stages ahead. Remember the hidden time cost: 3-6 months to find, 3-6 to ramp, 3-6 to fire if wrong, that is 18 months gone. This is why serial founders with existing networks ramp faster, though first-time founders bring naivety and clean-slate vision (Goldberg’s preference, especially those with a chip on their shoulder from a prior failed attempt).
• Lean into competitive markets if you have the conviction to outcompete. A crowded market validates the opportunity; ideas are a dime a dozen, execution wins.

Career and operating advice for investors / new fund managers

• Every VC should raise a fund before investing, the empathy from sitting on the pitching side reorients how you treat founders.
• Give real, direct feedback when passing. Polite no’s protect feelings but help no one and erode your reputation among GPs and LPs alike. The best LPs (and GPs) are clear, direct, and communicative.
• Single-trigger decision-making at the early stage beats consensus. Consensus votes filter out the conviction outliers that produce the biggest winners.
• Use light reserves at the early stage. “Peanut buttering” reserves into every pro rata is bad for the founder and the LPs; reserve only for clear exceptions.
• Capital concentration: keep no single company above ~10% of fund unless you have extraordinary conviction. Be willing to flex check size up before flexing ownership down to be in a category winner.
• Don’t be afraid of brand deals with small ownership at this stage of the cycle, especially in AI. Alignment with great founders compounds over time.
• Beware “knowing too much” in a vertical. East Coast fintech specialists outsmarted themselves out of every big winner; West Coast generalists’ naivety paid off. Knowledge can be a trap that filters out the crazy ideas that work.
• For new firms: meet LPs in person, pre-screen for first-fund appetite (ask what first-time funds they’ve backed in the last 2 years), build a deliberately uncorrelated LP base, and move fast, conviction in 2 weeks signals a great LP.

Tech / industry patterns

• “Industrialization” of venture: AUM up, team sizes up, partner anonymity up. Most checkwriters at big platforms are no longer household names even within their firms.
• Portfolio services teams (talent, BD, sales support) are largely VC scaling infrastructure dressed up as founder value; founders want direct GP relationships, not disintermediation.
• Series A check sizes have roughly doubled in 5 years ($15M deals are now $30-40M). A “Series A fund” is now a stage philosophy, not a check size.
• The AI bubble’s oxygen is starting to leak: .AI suffix premium is shrinking, and the .XYZ-crypto-to-.AI migrants will be evaluated as real businesses. But the very top of the AI infra stack still sees insane rounds (e.g., $750M pre-product reported).
• Liquidity for late-stage privates will increasingly come from new secondary products; expect fund durations to stretch beyond the assumed 10 years (LPs report 15+ years is now common).
• Lending businesses remain structurally hard; most fintech wins come from infrastructure and rails, not consumer lending.
• A generational turnover is underway in venture, mirroring a company-investing “why now.” New-guard firms (Conviction/Sarah Guo, Alt Capital/Jack Altman, Chemistry, 20VC) are emerging precisely as legacy institutions wrestle with succession and bloated portfolios.

Chapter Summaries

1. Why another VC firm? Goldberg argues the world doesn’t need another fund but does need a new fund: small, focused, experienced-GP-only, with values aligned to founders. Chemistry is $350M for seed and Series A.
2. The bureaucracy of large funds. Multinational fund operations create a people-management tax; portfolio services teams scale the VC, not the founder. Direct GP-founder relationships are the real product.
3. The “do no harm” debate. Stebbings says 90% of VCs add no value and the bar is just not hurting; Goldberg counters that at the early stage, trust-relationship moments (the 11pm Saturday call) materially shape outcomes.
4. Brand vs. boutique. Younger / Silicon-Valley-outside founders chase household brands; serial founders who’ve seen the multi-stage product up close go for the person. Chemistry is a deliberate reversion toward boutique (Benchmark, USV as inspirations).
5. Fund construction. $350M built bottoms-up from 2-3 investments/GP/year, ~25 deals per fund over 3 years, $10-15M lead Series A checks, very light reserves, no consensus voting (single-trigger model).
6. Round sizes, valuations, and the price-as-commitment frame. Stebbings’ “you pick the price but must 3x it” tactic is producing smaller, more deliberate seed valuations from founders.
7. AI bubble status. Goldberg sees oxygen leaking from the middle; Stebbings disagrees, citing $750M pre-product rounds. Both agree the .AI premium is fading.
8. Execution failures. Pre-PMF it’s founder grit and learning velocity. Post-PMF it’s hiring, especially go-to-market leadership transitions out of founder-led sales.
9. Founder profile preference. First-time founders win on naivety and vision; serial founders win on network and ramp speed. Goldberg leans first-time-with-a-chip-on-their-shoulder.
10. Markets and category traps. Competitive markets are fine if the founder can outcompete; “knowing too much” about a vertical can filter out the very ideas that win (fintech case study).
11. Fundraising the fund. ~100 LP meetings June-August, oversubscribed, deliberately uncorrelated 20-LP base, deepest empathy lesson: a meeting that’s one of many for the LP is the most important meeting of your day.
12. Partnership decisions. Biggest internal disagreement was whether to hire a junior team (landed on a very small two-person team, no hierarchy); in-office every day; single-trigger investment decisions.
13. State of venture. Industrialization, generational turnover, extended privatization windows, 2021 vintage challenges, and the rise of new-guard challenger firms.
14. Quick fire. Biggest mentor: Mike Volpi. Wants to change: venture group-think and gossip velocity. Biggest self-improvement area: reorienting time fully to offense (only possible with a clean slate).